Xucheng Hou

Xucheng Hou's research focuses on developing lipid-based nanoparticle systems for delivering RNA medicines (like mRNA) and treating drug-resistant bacterial infections. Work spans designing lipid nanoparticles (tiny fat-based capsules that carry genetic material into cells) for mRNA vaccines and therapies, as well as antimicrobial strategies against pathogens such as MRSA using nanotechnology and immune-based approaches. The group also investigates biofilm-disrupting materials, which target the protective layers bacteria form to resist treatment.

Publication output has fluctuated over the last decade with a notable peak in 2020 and 2025, suggesting an active but variable research pace rather than a strictly steady or continuously growing trend.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026